Matching placebo transdermal patch

DRUG2 trials

Sponsors

Purdue Pharma LP, The Third Xiangya Hospital of Central South University

Conditions

Healthy ParticipantsHealthy Volunteers

Phase 1

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

CompletedNCT01148537

Purdue Pharma LPHealthy Volunteers

Start: 2004-07-31End: 2004-12-31Updated: 2012-09-03

Safety, Tolerability, and Pharmacokinetics of DM1001 Transdermal Patch in Healthy Chinese Participants

Not yet recruitingNCT07844954

The Third Xiangya Hospital of Central South UniversityHealthy Participants

Start: 2026-09-30End: 2027-12-31Target: 66Updated: 2026-09-28